"Ronkainen, Hanna" - Selaus tekijän mukaan TUNICRIS-julkaisut
-
Eturauhassyöpä Käypä hoito -suosituksen tiivistelmä perusterveydenhuollolle
Matikainen, Mika; Kimmo, Taari; Boström, Peter; Kenttämies, Anu; Paula, Lindholm; Marttila, Timo; Mirtti, Tuomas; Murtola, Teemu; Nykopp, Timo; Rannikko, Antti; Ronkainen, Hanna; Seikkula, Heikki; Seppänen, Marko; Sipilä, Raija; Sundström, Eeva; Tikkinen, Kari AO; Utriainen, Tapio (2023)
article -
Intraoperative complications in kidney tumor surgery : critical grading for the European Association of Urology intraoperative adverse incident classification
Nisen, Harry; Erkkilä, Kaisa; Ettala, Otto; Ronkainen, Hanna; Isotalo, Taina; Nykopp, Timo; Seikkula, Heikki; Seppänen, Marjo; Tramberg, Margus; Palmberg, Christian; Kilponen, Ansa; Pogodin-Hannolainen, Dimitri; Mustonen, Sirkku; Veitonmäki, Thea (2022)
articleIntroduction: The European Association of Urology committee in 2020 suggested a new classification, intraoperative adverse incident classification (EAUiaiC), to grade intraoperative adverse events (IAE) in urology. Aims: ... -
Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy : study protocol
Siltari, Aino; Riikonen, Jarno; Koskimäki, Juha; Pakarainen, Tomi; Ettala, Otto; Boström, Peter; Seikkula, Heikki; Kotsar, Andres; Tammela, Teuvo; Helminen, Mika; Raittinen, Paavo V.; Lehtimäki, Terho; Fode, Mikkel; Østergren, Peter; Borre, Michael; Rannikko, Antti; Marttila, Timo; Salonen, Arto; Ronkainen, Hanna; Löffeler, Sven; Murtola, Teemu J. (29.04.2022)
articleINTRODUCTION: Blood cholesterol is likely a risk factor for prostate cancer prognosis and use of statins is associated with lowered risk of prostate cancer recurrence and progression. Furthermore, use of statins has been ...